LYFCX Mutual Fund

LYFCX Mutual Fund

NAV$18.12

Fund Essentials - as of Mar 31, 2026

Net Assets
$2M
Expense Ratio
2.46%
Dividend Yield (Current)
0.66%
Holdings
63
Inception Date
Nov 29, 2019
Fund Family
Alpha Centric Fund
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+12.86%
1 Year+49.52%
3 Year+8.67%
5 Year+7.51%

Asset Allocation

Stocks: 92.29%
Cash: 7.71%

Top Holdings

View All →
TickerNameWeight
FXFXXFirst Am Treas Obli-X7.72%
GILDGilead Sciences7.18%
AZN:LNAstrazeneca Plc5.63%
VRTXNvaesrtex Pharmaceuticals Inc5.60%
IONSIonis Pharmaceuticals Inc3.74%
Top 10 Concentration: 46.76%Report Date: Mar 31, 2026
Download all 63 holdings for LYFCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.66%
Frequency
Annually
Latest Distribution
$1.58
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how LYFCX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

LYFCX Mutual Fund Overview

LYFCX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class C) is managed by Alpha Centric Fund with $2.0M in net assets. LYFCX expense ratio is 2.46%, holding 63 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.

LYFCX performance shows a YTD return of 12.86%. The 1-year return is 49.52% and the 5-year return is 7.51%. LYFCX dividend yield stands at 0.66%, paid annually.

LYFCX top holdings include First Am Treas Obli-X (7.7%), Gilead Sciences (7.2%), Astrazeneca Plc (5.6%), Nvaesrtex Pharmaceuticals Inc (5.6%), Ionis Pharmaceuticals Inc (3.7%). Go to all LYFCX holdings, LYFCX sectors, or LYFCX dividends.

LYFCX can be compared against other funds. Use LYFCX overlap to find shared positions, or LYFCX vs another fund for a side-by-side view. LYFCX alternatives are available via the screener, along with tax-loss harvesting opportunities.